Surgical site infection in implant-based breast reconstruction is a complication with variable incidence reported in the literature. Due to potential loss of implant and reconstruction, it can have a strong psychological impact on patients. Background and objectives: This study aimed primarily at analyzing the current status of the surgical site infection (SSI), (type, time of onset, clinical presentation, pathogens and management) in patients who underwent implant-based breast reconstruction at our Breast Unit. Secondarily, we wanted to establish whether introduction of a new, updated evidence-based protocol for infection prevention can reduce SSI in implant-based breast reconstruction. Materials and Methods: A single-center retrospective study was performed primarily to evaluate the incidence and features of SSI after implant-based breast reconstruction from 2007 to 2020. In June 2020, a protocol for prevention of SSI in implant-based breast reconstruction was introduced in clinical practice. Secondarily, a data analysis of all patients who underwent implant-based breast reconstruction in compliance with this protocol was performed after preliminarily assessing its efficacy. Results: 756 women were evaluated after mastectomy and implant-based breast reconstruction for breast cancer. A total of 26 surgical site infections were detected. The annual incidence of SSI decreased over time (range 0-11.76%). Data relating to infections' features, involved pathogens and implemented treatments were obtained. Since the introduction of the protocol, 22 patients have been evaluated, for a total of 29 implants. No early infections occurred. Conclusions: Surgical site infection rates at our Breast Unit are comparable to those reported in the literature. The SSI rates have shown a decreasing trend over the years. No SSI has occurred since the introduction of the prevention protocol for surgical site infection in June 2020.
Surgical site infection in implant-based breast reconstruction is a complication with variable incidence reported in the literature. Due to potential loss of implant and reconstruction, it can have a strong psychological impact on patients. Background and objectives: This study aimed primarily at analyzing the current status of the surgical site infection (SSI), (type, time of onset, clinical presentation, pathogens and management) in patients who underwent implant-based breast reconstruction at our Breast Unit. Secondarily, we wanted to establish whether introduction of a new, updated evidence-based protocol for infection prevention can reduce SSI in implant-based breast reconstruction. Materials and Methods: A single-center retrospective study was performed primarily to evaluate the incidence and features of SSI after implant-based breast reconstruction from 2007 to 2020. In June 2020, a protocol for prevention of SSI in implant-based breast reconstruction was introduced in clinical practice. Secondarily, a data analysis of all patients who underwent implant-based breast reconstruction in compliance with this protocol was performed after preliminarily assessing its efficacy. Results: 756 women were evaluated after mastectomy and implant-based breast reconstruction for breast cancer. A total of 26 surgical site infections were detected. The annual incidence of SSI decreased over time (range 0-11.76%). Data relating to infections' features, involved pathogens and implemented treatments were obtained. Since the introduction of the protocol, 22 patients have been evaluated, for a total of 29 implants. No early infections occurred. Conclusions: Surgical site infection rates at our Breast Unit are comparable to those reported in the literature. The SSI rates have shown a decreasing trend over the years. No SSI has occurred since the introduction of the prevention protocol for surgical site infection in June 2020.
Entities:
Keywords:
antibiotic prophylaxis; breast reconstruction; complication; implant; infection; prevention
Authors: Brett T Phillips; Mitchell S Fourman; Muath Bishawi; Mary Zegers; Brian J O'Hea; Jason C Ganz; Tara L Huston; Alexander B Dagum; Sami U Khan; Duc T Bui Journal: J Am Coll Surg Date: 2016-03-04 Impact factor: 6.113
Authors: Amy S Colwell; Oren Tessler; Alex M Lin; Eric Liao; Jonathan Winograd; Curtis L Cetrulo; Rong Tang; Barbara L Smith; William G Austen Journal: Plast Reconstr Surg Date: 2014-03 Impact factor: 4.730
Authors: Katelyn G Bennett; Ji Qi; Hyungjin M Kim; Jennifer B Hamill; Andrea L Pusic; Edwin G Wilkins Journal: JAMA Surg Date: 2018-10-01 Impact factor: 14.766
Authors: Anuja K Antony; Colleen M McCarthy; Peter G Cordeiro; Babak J Mehrara; Andrea L Pusic; Esther H Teo; Alexander F Arriaga; Joseph J Disa Journal: Plast Reconstr Surg Date: 2010-06 Impact factor: 4.730
Authors: Indranil Sinha; Andrea L Pusic; Edwin G Wilkins; Jennifer B Hamill; Xiaoxue Chen; Hyungjin M Kim; Gretchen Guldbrandsen; Yoon S Chun Journal: Plast Reconstr Surg Date: 2017-01 Impact factor: 4.730
Authors: Richard G Reish; Branimir Damjanovic; William G Austen; Jonathan Winograd; Eric C Liao; Curtis L Cetrulo; Daniel M Balkin; Amy S Colwell Journal: Plast Reconstr Surg Date: 2013-06 Impact factor: 4.730
Authors: Andrea Sisti; Maria T Huayllani; Daniel Boczar; David J Restrepo; Aaron C Spaulding; Gabriel Emmanuel; Sanjay P Bagaria; Sarah A McLaughlin; Alexander S Parker; Antonio J Forte Journal: Acta Biomed Date: 2020-05-11
Authors: S P Barr; A R Topps; N L P Barnes; J Henderson; S Hignett; R L Teasdale; A McKenna; J R Harvey; C C Kirwan Journal: Eur J Surg Oncol Date: 2016-02-27 Impact factor: 4.424